Comments to FDA: Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology Share page: Docket Number: FDA-2010-D-0530 CHPA applauds the approach for creating a public forum to collect current research and comments to advance the science of engineered nanomaterials. Download Document Issues: OTC Medicines Sunscreen Other Issues Quality Related Posts Press Releases and Statements CHPA Highlights Critical Importance of Consumer Healthcare, Warns of Unintended Consequences from Tariffs Feb 3, 2025 Press Releases and Statements CHPA Strengthens Regulatory Team with Two Accomplished Industry Experts Jan 31, 2025 Effectiveness of Phenylephrine as an Oral Decongestant